geomx Search Results


90
Spatial Transcriptomics Inc geomx spatial transcriptomics
Geomx Spatial Transcriptomics, supplied by Spatial Transcriptomics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/geomx/geomx/pm39846634-101-14-15
Average 90 stars, based on 1 article reviews
geomx spatial transcriptomics - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Spatial Transcriptomics Inc geomx® digital spatial profiler (dsp)
Geomx® Digital Spatial Profiler (Dsp), supplied by Spatial Transcriptomics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/geomx/geomx+digital+spatial+profiler/pmc09401975__mmc1-87-19-0
Average 90 stars, based on 1 article reviews
geomx® digital spatial profiler (dsp) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Mendeley Ltd geomx dsp
Geomx Dsp, supplied by Mendeley Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/geomx/geomx+dsp/pmc12236807-742-0-12
Average 90 stars, based on 1 article reviews
geomx dsp - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Visiopharm AS geomx dsp immuno-oncology protein panel assay
Geomx Dsp Immuno Oncology Protein Panel Assay, supplied by Visiopharm AS, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/geomx/geomx+dsp+immuno+oncology+protein+panel+assay/pm39635525-272-4-13
Average 90 stars, based on 1 article reviews
geomx dsp immuno-oncology protein panel assay - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
10X Genomics geomx dsp
Geomx Dsp, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/geomx/geomx+dsp/pmc11829416-68-5-1
Average 90 stars, based on 1 article reviews
geomx dsp - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Colorbar Inc geomx cancer transcriptome atlas
(a) t-SNE of immune and stroma cell profiles (dots), colored by inferred cell type (left) or sample (right). (b) Cytotoxicity (x axis) and exhaustion (y axis) scores of SyS CD8 T cells, colored by the T cell expansion program score. The latter is associated with high cytotoxicity and lower than expected exhaustion (P < 1*10−11, mixed-effects). (c) Distribution of effector vs. exhaustion scores (top) or an immune checkpoint blockade responsiveness program39 (bottom) in CD8 T cells from SyS (orange) and melanoma (green); p-value: mixed-effects test. (d) Overall Expression of the immune signatures (y axis) in SyS tumors (orange) and other cancer types (controlling for variation in the mutational load, left panel) or other sarcomas (right panel). (e) Inferred level of immune cell types is associated with the malignant programs in bulk SyS tumors, when controlling for tumor purity. Partial correlation (colorbar) between the inferred level of each immune subset (rows) and the core oncogenic and differentiation levels (columns). (f-h) <t>GeoMx</t> Cancer <t>Transcriptome</t> Atlas (TA) and Whole Transcriptome Atlas in situ profiling reveals that the core oncogenic program (COP) is associated with reduced immune infiltrates. (f) Representative CD45+ staining in COP-high and COP-low tumor niches; the trend was observed across 244 ROIs in 9 SyS tumors, as shown in (g) and (h); (g) the expression of the COP in malignant CD45− AOIs stratified according to the immune cell abundance in the pertaining ROI, with no. of ROIs in parenthesis; p-values: mixed-effects test. (h) association gene expression in malignant CD45− AOIs with immune abundance in the pertaining ROI. (d) and (g) middle line: median; box edges: 25th and 75th percentiles, whiskers: most extreme points that do not exceed ±IQR*1.5; further outliers are marked individually.
Geomx Cancer Transcriptome Atlas, supplied by Colorbar Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/geomx/geomx+cancer+transcriptome+atlas/pmc08817899-109-20-2
Average 90 stars, based on 1 article reviews
geomx cancer transcriptome atlas - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Biotechnology Information geomx dsp analysis software
(a) t-SNE of immune and stroma cell profiles (dots), colored by inferred cell type (left) or sample (right). (b) Cytotoxicity (x axis) and exhaustion (y axis) scores of SyS CD8 T cells, colored by the T cell expansion program score. The latter is associated with high cytotoxicity and lower than expected exhaustion (P < 1*10−11, mixed-effects). (c) Distribution of effector vs. exhaustion scores (top) or an immune checkpoint blockade responsiveness program39 (bottom) in CD8 T cells from SyS (orange) and melanoma (green); p-value: mixed-effects test. (d) Overall Expression of the immune signatures (y axis) in SyS tumors (orange) and other cancer types (controlling for variation in the mutational load, left panel) or other sarcomas (right panel). (e) Inferred level of immune cell types is associated with the malignant programs in bulk SyS tumors, when controlling for tumor purity. Partial correlation (colorbar) between the inferred level of each immune subset (rows) and the core oncogenic and differentiation levels (columns). (f-h) <t>GeoMx</t> Cancer <t>Transcriptome</t> Atlas (TA) and Whole Transcriptome Atlas in situ profiling reveals that the core oncogenic program (COP) is associated with reduced immune infiltrates. (f) Representative CD45+ staining in COP-high and COP-low tumor niches; the trend was observed across 244 ROIs in 9 SyS tumors, as shown in (g) and (h); (g) the expression of the COP in malignant CD45− AOIs stratified according to the immune cell abundance in the pertaining ROI, with no. of ROIs in parenthesis; p-values: mixed-effects test. (h) association gene expression in malignant CD45− AOIs with immune abundance in the pertaining ROI. (d) and (g) middle line: median; box edges: 25th and 75th percentiles, whiskers: most extreme points that do not exceed ±IQR*1.5; further outliers are marked individually.
Geomx Dsp Analysis Software, supplied by Biotechnology Information, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/geomx/geomx+dsp+analysis+software/pm40163757-65-45-16
Average 90 stars, based on 1 article reviews
geomx dsp analysis software - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Department of Immunotechnology Lunds University geomx instrument
(a) t-SNE of immune and stroma cell profiles (dots), colored by inferred cell type (left) or sample (right). (b) Cytotoxicity (x axis) and exhaustion (y axis) scores of SyS CD8 T cells, colored by the T cell expansion program score. The latter is associated with high cytotoxicity and lower than expected exhaustion (P < 1*10−11, mixed-effects). (c) Distribution of effector vs. exhaustion scores (top) or an immune checkpoint blockade responsiveness program39 (bottom) in CD8 T cells from SyS (orange) and melanoma (green); p-value: mixed-effects test. (d) Overall Expression of the immune signatures (y axis) in SyS tumors (orange) and other cancer types (controlling for variation in the mutational load, left panel) or other sarcomas (right panel). (e) Inferred level of immune cell types is associated with the malignant programs in bulk SyS tumors, when controlling for tumor purity. Partial correlation (colorbar) between the inferred level of each immune subset (rows) and the core oncogenic and differentiation levels (columns). (f-h) <t>GeoMx</t> Cancer <t>Transcriptome</t> Atlas (TA) and Whole Transcriptome Atlas in situ profiling reveals that the core oncogenic program (COP) is associated with reduced immune infiltrates. (f) Representative CD45+ staining in COP-high and COP-low tumor niches; the trend was observed across 244 ROIs in 9 SyS tumors, as shown in (g) and (h); (g) the expression of the COP in malignant CD45− AOIs stratified according to the immune cell abundance in the pertaining ROI, with no. of ROIs in parenthesis; p-values: mixed-effects test. (h) association gene expression in malignant CD45− AOIs with immune abundance in the pertaining ROI. (d) and (g) middle line: median; box edges: 25th and 75th percentiles, whiskers: most extreme points that do not exceed ±IQR*1.5; further outliers are marked individually.
Geomx Instrument, supplied by Department of Immunotechnology Lunds University, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/geomx/geomx+instrument/pmc09980604__KONI_A_2184130_SM6068-31-6-13
Average 90 stars, based on 1 article reviews
geomx instrument - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
10X Genomics geomx dsp instrument software
(a) t-SNE of immune and stroma cell profiles (dots), colored by inferred cell type (left) or sample (right). (b) Cytotoxicity (x axis) and exhaustion (y axis) scores of SyS CD8 T cells, colored by the T cell expansion program score. The latter is associated with high cytotoxicity and lower than expected exhaustion (P < 1*10−11, mixed-effects). (c) Distribution of effector vs. exhaustion scores (top) or an immune checkpoint blockade responsiveness program39 (bottom) in CD8 T cells from SyS (orange) and melanoma (green); p-value: mixed-effects test. (d) Overall Expression of the immune signatures (y axis) in SyS tumors (orange) and other cancer types (controlling for variation in the mutational load, left panel) or other sarcomas (right panel). (e) Inferred level of immune cell types is associated with the malignant programs in bulk SyS tumors, when controlling for tumor purity. Partial correlation (colorbar) between the inferred level of each immune subset (rows) and the core oncogenic and differentiation levels (columns). (f-h) <t>GeoMx</t> Cancer <t>Transcriptome</t> Atlas (TA) and Whole Transcriptome Atlas in situ profiling reveals that the core oncogenic program (COP) is associated with reduced immune infiltrates. (f) Representative CD45+ staining in COP-high and COP-low tumor niches; the trend was observed across 244 ROIs in 9 SyS tumors, as shown in (g) and (h); (g) the expression of the COP in malignant CD45− AOIs stratified according to the immune cell abundance in the pertaining ROI, with no. of ROIs in parenthesis; p-values: mixed-effects test. (h) association gene expression in malignant CD45− AOIs with immune abundance in the pertaining ROI. (d) and (g) middle line: median; box edges: 25th and 75th percentiles, whiskers: most extreme points that do not exceed ±IQR*1.5; further outliers are marked individually.
Geomx Dsp Instrument Software, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/geomx/geomx+dsp+instrument+software/10__1158_slash_1078___0432__ccr___23___0219-49-14-42
Average 90 stars, based on 1 article reviews
geomx dsp instrument software - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
10X Genomics hybrid geomx dsp
Summary of studies using spatial transcriptomics in human cardiac tissues. FFPE, formalin-fixed paraffin-embedded; <t> GeoMx DSP, </t> GeoMx Digital Spatial Profiler; hPSC, human pluripotent stem cell; ISH, in situ hybridization; ISS, in situ sequencing; MERFISH, multiplexed error-robust fluorescence in situ hybridization; OCT, optimal cutting temperature; scATAC-seq, single-cell assay for transposase-accessible chromatin sequencing; scCITE-seq, single-cell cellular indexing of transcriptomes and epitopes sequencing; scRNA-seq, single-cell RNA sequencing; ST, spatial transcriptomics.
Hybrid Geomx Dsp, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/geomx/hybrid+geomx+dsp/pmc11817049-14-13-18
Average 90 stars, based on 1 article reviews
hybrid geomx dsp - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Oligos Etc geomx digital spatial profiler
Summary of studies using spatial transcriptomics in human cardiac tissues. FFPE, formalin-fixed paraffin-embedded; <t> GeoMx DSP, </t> GeoMx Digital Spatial Profiler; hPSC, human pluripotent stem cell; ISH, in situ hybridization; ISS, in situ sequencing; MERFISH, multiplexed error-robust fluorescence in situ hybridization; OCT, optimal cutting temperature; scATAC-seq, single-cell assay for transposase-accessible chromatin sequencing; scCITE-seq, single-cell cellular indexing of transcriptomes and epitopes sequencing; scRNA-seq, single-cell RNA sequencing; ST, spatial transcriptomics.
Geomx Digital Spatial Profiler, supplied by Oligos Etc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/geomx/geomx+digital+spatial+profiler/pm35111697-40-9-0
Average 90 stars, based on 1 article reviews
geomx digital spatial profiler - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
CapitalBio Corporation geomx digital spatial profiling platform
Summary of studies using spatial transcriptomics in human cardiac tissues. FFPE, formalin-fixed paraffin-embedded; <t> GeoMx DSP, </t> GeoMx Digital Spatial Profiler; hPSC, human pluripotent stem cell; ISH, in situ hybridization; ISS, in situ sequencing; MERFISH, multiplexed error-robust fluorescence in situ hybridization; OCT, optimal cutting temperature; scATAC-seq, single-cell assay for transposase-accessible chromatin sequencing; scCITE-seq, single-cell cellular indexing of transcriptomes and epitopes sequencing; scRNA-seq, single-cell RNA sequencing; ST, spatial transcriptomics.
Geomx Digital Spatial Profiling Platform, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/geomx/geomx+digital+spatial+profiling+platform/pm40543508-268-24-2
Average 90 stars, based on 1 article reviews
geomx digital spatial profiling platform - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


(a) t-SNE of immune and stroma cell profiles (dots), colored by inferred cell type (left) or sample (right). (b) Cytotoxicity (x axis) and exhaustion (y axis) scores of SyS CD8 T cells, colored by the T cell expansion program score. The latter is associated with high cytotoxicity and lower than expected exhaustion (P < 1*10−11, mixed-effects). (c) Distribution of effector vs. exhaustion scores (top) or an immune checkpoint blockade responsiveness program39 (bottom) in CD8 T cells from SyS (orange) and melanoma (green); p-value: mixed-effects test. (d) Overall Expression of the immune signatures (y axis) in SyS tumors (orange) and other cancer types (controlling for variation in the mutational load, left panel) or other sarcomas (right panel). (e) Inferred level of immune cell types is associated with the malignant programs in bulk SyS tumors, when controlling for tumor purity. Partial correlation (colorbar) between the inferred level of each immune subset (rows) and the core oncogenic and differentiation levels (columns). (f-h) GeoMx Cancer Transcriptome Atlas (TA) and Whole Transcriptome Atlas in situ profiling reveals that the core oncogenic program (COP) is associated with reduced immune infiltrates. (f) Representative CD45+ staining in COP-high and COP-low tumor niches; the trend was observed across 244 ROIs in 9 SyS tumors, as shown in (g) and (h); (g) the expression of the COP in malignant CD45− AOIs stratified according to the immune cell abundance in the pertaining ROI, with no. of ROIs in parenthesis; p-values: mixed-effects test. (h) association gene expression in malignant CD45− AOIs with immune abundance in the pertaining ROI. (d) and (g) middle line: median; box edges: 25th and 75th percentiles, whiskers: most extreme points that do not exceed ±IQR*1.5; further outliers are marked individually.

Journal: Nature medicine

Article Title: Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcoma

doi: 10.1038/s41591-020-01212-6

Figure Lengend Snippet: (a) t-SNE of immune and stroma cell profiles (dots), colored by inferred cell type (left) or sample (right). (b) Cytotoxicity (x axis) and exhaustion (y axis) scores of SyS CD8 T cells, colored by the T cell expansion program score. The latter is associated with high cytotoxicity and lower than expected exhaustion (P < 1*10−11, mixed-effects). (c) Distribution of effector vs. exhaustion scores (top) or an immune checkpoint blockade responsiveness program39 (bottom) in CD8 T cells from SyS (orange) and melanoma (green); p-value: mixed-effects test. (d) Overall Expression of the immune signatures (y axis) in SyS tumors (orange) and other cancer types (controlling for variation in the mutational load, left panel) or other sarcomas (right panel). (e) Inferred level of immune cell types is associated with the malignant programs in bulk SyS tumors, when controlling for tumor purity. Partial correlation (colorbar) between the inferred level of each immune subset (rows) and the core oncogenic and differentiation levels (columns). (f-h) GeoMx Cancer Transcriptome Atlas (TA) and Whole Transcriptome Atlas in situ profiling reveals that the core oncogenic program (COP) is associated with reduced immune infiltrates. (f) Representative CD45+ staining in COP-high and COP-low tumor niches; the trend was observed across 244 ROIs in 9 SyS tumors, as shown in (g) and (h); (g) the expression of the COP in malignant CD45− AOIs stratified according to the immune cell abundance in the pertaining ROI, with no. of ROIs in parenthesis; p-values: mixed-effects test. (h) association gene expression in malignant CD45− AOIs with immune abundance in the pertaining ROI. (d) and (g) middle line: median; box edges: 25th and 75th percentiles, whiskers: most extreme points that do not exceed ±IQR*1.5; further outliers are marked individually.

Article Snippet: Partial correlation (colorbar) between the inferred level of each immune subset (rows) and the core oncogenic and differentiation levels (columns). (f-h) GeoMx Cancer Transcriptome Atlas (TA) and Whole Transcriptome Atlas in situ profiling reveals that the core oncogenic program (COP) is associated with reduced immune infiltrates. (f) Representative CD45 + staining in COP-high and COP-low tumor niches; the trend was observed across 244 ROIs in 9 SyS tumors, as shown in (g) and (h); (g) the expression of the COP in malignant CD45 − AOIs stratified according to the immune cell abundance in the pertaining ROI, with no. of ROIs in parenthesis; p-values: mixed-effects test. (h) association gene expression in malignant CD45 − AOIs with immune abundance in the pertaining ROI. (d) and (g) middle line: median; box edges: 25 th and 75 th percentiles, whiskers: most extreme points that do not exceed ±IQR*1.5; further outliers are marked individually.

Techniques: Expressing, In Situ, Staining, Gene Expression

Summary of studies using spatial transcriptomics in human cardiac tissues. FFPE, formalin-fixed paraffin-embedded;  GeoMx DSP,  GeoMx Digital Spatial Profiler; hPSC, human pluripotent stem cell; ISH, in situ hybridization; ISS, in situ sequencing; MERFISH, multiplexed error-robust fluorescence in situ hybridization; OCT, optimal cutting temperature; scATAC-seq, single-cell assay for transposase-accessible chromatin sequencing; scCITE-seq, single-cell cellular indexing of transcriptomes and epitopes sequencing; scRNA-seq, single-cell RNA sequencing; ST, spatial transcriptomics.

Journal: International Journal of Molecular Sciences

Article Title: Spatial Transcriptomics in Human Cardiac Tissue

doi: 10.3390/ijms26030995

Figure Lengend Snippet: Summary of studies using spatial transcriptomics in human cardiac tissues. FFPE, formalin-fixed paraffin-embedded; GeoMx DSP, GeoMx Digital Spatial Profiler; hPSC, human pluripotent stem cell; ISH, in situ hybridization; ISS, in situ sequencing; MERFISH, multiplexed error-robust fluorescence in situ hybridization; OCT, optimal cutting temperature; scATAC-seq, single-cell assay for transposase-accessible chromatin sequencing; scCITE-seq, single-cell cellular indexing of transcriptomes and epitopes sequencing; scRNA-seq, single-cell RNA sequencing; ST, spatial transcriptomics.

Article Snippet: , Vyas et al. [ ] , 2024 , FFPE , Hybrid , GeoMx DSP , scRNA-seq, scCITE-seq (10x Genomics) , Yes (hPSC model).

Techniques: Formalin-fixed Paraffin-Embedded, In Situ Hybridization, In Situ, Sequencing, Fluorescence, RNA Sequencing, Imaging